John Nosenzo appointed chief commercial officer of Bioventus

John Nosenzo

Bioventus has named John Nosenzo as chief commercial officer. Nosenzo has worked in sales and marketing in the pharmaceutical and medical diagnostics areas markets for over 25 years.

He will be responsible for leading all global sales and distributor management functions for Bioventus, as well as global marketing for the Active Healing Therapies business. He will also lead key customer interface functions responsible for expanding Bioventus’ market access and for providing reimbursement services for the Exogen ultrasound bone healing system.

Nosenzo will report to chief executive officer Tony Bihl and serve as a member of the Bioventus executive leadership team. He will begin work on February 6 2017.

“John is a natural charismatic leader who develops top talent, builds strong teams, and consistently delivers exceptional sales results,” says Bihl.

From 2011, Nosenzo was senior vice president, Global Customer Operations at Beckman Coulter Diagnostics. Previously, he was senior vice president, Customer Relations Management for Siemens Healthcare, and vice president, Marketing and Sales at Quest Diagnostics.

Nosenzo began his career with Bayer Healthcare, progressively growing thorough sales leadership roles in pharmaceuticals and diagnostic testing businesses over 20+ years, ultimately achieving the role of Senior Vice President, General Manager- Americas for Bayer Diagnostics, prior to the acquisition of this business by Siemens AG.

He earned a Masters’ of Business Administration degree in marketing and management from Adelphi University, Garden City, USA, and a Bachelor of Science in pharmacy from St John’s University, Queens, USA.